| 1 |
Zheng ZL. Interventional chemotherapy and concurrent toxicity chemotherapy and concurrent radio-therapy on 89 patients with advanced cervical cancer[J]. J Mod Oncol, 2013,21(1) : 150-152.
|
| 2 |
Gao Y, Zhang X, Wang CY. Response and toxicity of concurrent chemoradiotherapy in the treatment for cervical cancer [J]. China Cance, 2013,(1): 74-76.
|
| 3 |
Phippen NT, Leath CA, Chino JP. Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages Ⅱ B to Ⅳ A carcinoma of the cervix[J]. Gynecol Oncol,2012,127(2) :267-272.
|
| 4 |
Kang S, Nam BH, Park JY. Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer : A Korean gynecologic oncology group study[J]. J Clin Oncol,2012,30(19) :2369-2374.
|
| 5 |
Ma D. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12 Chin J Obstet Gynecol Pediatr:Electron Ed, 2013,9(5): 112.
|
| 6 |
Tang KW, Du PY, Wu YY. Concurrent chemoradiotherapy with neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer clinical evaluation [J]. Guid China Med, 2012,10 (27): 98-99.
|
| 7 |
Lee HJ, Kim YS, Shin SS. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer[J]. Tumori,2012,98(5) : 615-621.
|
| 8 |
Li XZ, Zou W, Li M. Effect of docetaxel combined with carboplatin in concurrent chemoradiotherapy of advanced cervical cancer in outpatient clinic[J]. Chin Gener Pract, 2012,15(30) : 3523-3525.
|
| 9 |
Liu SY, Li GW, Chen ZR, et al. Clinical approach of combined treatment on advanced cervical carcinoma [J/CD]. Chin J Obstet Gynecol Pediatr:Electron Ed,2011,(5) :458-460.
|
| 10 |
Lin X D, Zhou T C, Shi X Y, et al. Clinical analysis of chemoradiotherapy in treatment of middle-late cervical cancer and factors of infection[J]. Chin J Nosocomilol, 2011,21(18) : 3876-3877.
|
| 11 |
Zhang H Y, Chen X Q, Zhang G L, et al. A clinical analysis of synchionizing radiotherapy and chemotherapy on cervical cancer at middle or advanced stage[J]. J Hainan MedCollege, 2007,13(5): 475-477.
|
| 12 |
Han M. The clinical research on concurrent radiotherapy and chemotherapy by paclitaxel plus cisplatin in advanced cervical cancer [J]. Chin J Clin Pract Med, 2007,8(2): 35-37.
|
| 13 |
Liang Y, Bydder M, Yashar CM. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies [J]. Int J Radiat Oncol Biol Phys,2013,85(2):406-414.
|
| 14 |
Chen Y F, Yang W, Pan X X, et al. Cinical research of paclitaxel and nedaplatin combined with megestrol synchronous radiotherapy and chemotherapy in advanced cervical cancer[J]. China Med Herald, 2013,10(13): 66-68.
|
| 15 |
Li X Z, Zou W, Li M, et al. Effect of docetaxel combined with carboplatin in concurrent chemoradiotherapy of advanced cervical cancer in outpatient clinic [J]. Chin Gen Pract, 2012,15(30): 3523-3525.
|
| 16 |
Bao H. Clinical efficacy of concurrent chemoradiotherapy and radiotherapy alone after operation for advanced cervical cancer[J]. China Mod Doctor, 2012,50(27): 15-16.
|
| 17 |
Fan Z G, Cui X B. Concurrent chemotherapy in advanced cervical cancer clinical research[J]. Pract J Cancer, 2012,27(3) : 309-311.
|
| 18 |
She W B. Concurrent chemoradiotherapy for advanced cervical cancer efficacy[J]. Contemp Med, 2012,18(23) : 98-99.
|
| 19 |
Deng GQ, Huang GY, Meng YL. Concurrent chemotherapy and radiotherapy in advanced cervical efficacy [J]. Guangxi Med J, 2012, 34(9): 1208-1209,1212.
|
| 20 |
Villeneuve H, Després P, Fortin B. Cervical lymph node metastases from unknown primary cancer: A single-institution experience with intensity-modulated radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2012,82(5):1866-1871.
|